Unknown

Dataset Information

0

Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage.

ABSTRACT:

SUBMITTER: Barsky BA 

PROVIDER: S-EPMC8739765 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Physician Reimbursement in Medicare Advantage Compared With Traditional Medicare and Commercial Health Insurance.
| S-EPMC5710575 | biostudies-literature
Unknown Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019.
| S-EPMC7851726 | biostudies-literature
Unknown Use of diabetes medications in traditional Medicare and Medicare Advantage.
| S-EPMC7967940 | biostudies-literature
Unknown The effects of medicare advantage on opioid use.
| S-EPMC7181702 | biostudies-literature
Unknown Service use at the end-of-life in Medicare advantage versus traditional Medicare.
| S-EPMC3804008 | biostudies-literature
Unknown Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.
| S-EPMC8397932 | biostudies-literature
Unknown The Comparative Advantage of Medicare Advantage.
| S-EPMC6481953 | biostudies-literature
Unknown Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance.
| S-EPMC8753497 | biostudies-literature
Unknown How Do the Hospital Prices Paid by Medicare Advantage Plans and Commercial Plans Compare With Medicare Fee-for-Service Prices?
| S-EPMC6050995 | biostudies-literature
Unknown Comparison of the Quality of Hospitals That Admit Medicare Advantage Patients vs Traditional Medicare Patients.
| S-EPMC6991262 | biostudies-literature